摘要：
2025年10月22 日, 北京大学药学院天然药物及仿生药物全国重点实验室吕万良教授团队在著名学术期刊Chemical Engineering Journal在线发表了题为Recombinant PD1 liposome loading nintedanib for pulmonary fibrosis therapy in mice的研究工作。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 吕万良团队研究了一种载尼达尼布基因重组PD1脂质体用于肺纤维化治疗[J]. 中国药学(英文版), 2025, 34(11): 1062-1062.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lv has studied a recombinant PD1 liposome loaded nintedanib for the treatment of pulmonary fibrosis[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(11): 1062-1062.
>
>